398 related articles for article (PubMed ID: 30961948)
1. Acute exacerbation of interstitial lung disease after procedures.
Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
[TBL] [Abstract][Full Text] [Related]
4. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
[TBL] [Abstract][Full Text] [Related]
7. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
[TBL] [Abstract][Full Text] [Related]
8. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute exacerbations of interstitial lung disease.
Azadeh N; Moua T; Baqir M; Ryu JH
Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
Singh P; Thakur B; Mohapatra AK; Padhan P
Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
[TBL] [Abstract][Full Text] [Related]
14. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
[TBL] [Abstract][Full Text] [Related]
15. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
Ishikawa G; Acquah SO; Salvatore M; Padilla ML
Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
Kimura T; Nojiri T; Hosoda H; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e85-91. PubMed ID: 26224340
[TBL] [Abstract][Full Text] [Related]
18. Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
Salonen J; Vähänikkilä H; Purokivi M; Kaarteenaho R
PLoS One; 2020; 15(11):e0242860. PubMed ID: 33253258
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
Callahan SJ; Xia M; Murray S; Flaherty KR
Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
[TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
